Andreea A. Nanci MD, MBA

picture of Andreea A. Nanci

Associate Clinical Professor, Division of Hematology/Oncology, Medicine
School of Medicine

Clinical Fellowship, Northwest Hospital, Johann W. Goethe-University, Frankfurt, Germany, 2005, Hematology/Oncology
Fellowship, University of California, Irvine, 2003, Hematology/Oncology
M.B.A., University of California, Irvine, 2013, Healthcare Executive MBA Program
Residency, Albert Einstein College of Medicine, Jacobi Medical Center and Einstein Hospital, Bronx, New York, 2000, Internal Medicine
M.D., Johann Wolfgang Goethe University Medical School, Frankfurt, Germany, 1995

Phone: (949) 999-2400
Fax: (949) 999-2405
Email: ananci@uci.edu

University of California, Irvine
UC Irvine Health Cancer Center - Newport
1640 Newport Blvd., Suite 400
Mail Code: 4061
Costa Mesa, CA 92627
Research Interests
Breast Cancer and Cancer Survivorship, including Integrative Medicine approaches to cancer
Publications
Dillman R, Nanci A, Williams S, Kim R, Hafer R, Coleman C, Wang P, Duma C, Chen P, Selvan S, Comforth A, DePriest C. Durable Complete Response of Refractory, Progressing Metastatic Melanoma After Treatment With A Patient-Specific Vaccine. Cancer Biotherapy and Radiopharmaceuticals: Volume 25, Number 5, 2010.
 
Hertel A, Baum RP, Nanci A, Schulte L, Suresh MR, Noujaim AA, Donnerstag B, Oltrogge J, and Hoer G. Influence of Anti-idiotypic HAMA on Three Different Tumor Marker Assays in Ovarian Cancer Patients. J of Nucl Med 1993; 34(5): 126, Abstract Book, Proceedings of the 40th Annual Nuclear Medicine Meeting
 
Baum RP, Noujaim AA, Nanci A; Moebus V, Hertel A, Niesen A, Donnerstag B, Sykes T, Boniface G, and Hoer G. Clinical Course of Ovarian Cancer Patients Under Repeated Stimulation ofHAMA Using Mab OC 125 and B43.13. Hybridoma 1993 Oct; 12(5): 583-9
 
Baum RP, Niesen A, Hertel A, Nancy (sic) A, Hess H, Donnerstag B, Sykes TR, Sykes CJ, Suresh MR, Noujaim AA, and Hoer G. Acitvating Anti-Idiotypic Human Anti-mouse Antibodies for Immunotherapy of Ovarian Carcinoma. Cancer Feb.l, 1994; 73(3 Suppl): 1121-5
 
Nelson EL, Nanci A, Alexander T, Kamrud K, Fralish B, and Smith J. Alphavirus replicon particles (VRP) with dendritic cell (DC) tropism and expressing a designed rat neu target antigen overcome tolerance and induce anti-tumor immunity in a rat mammary tumor model. Abstract #1999, Proceedings of the American Association for Cancer Research (AACR), Volume 44, March 2003
Professional Societies
American Society of Hematology (ASH)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
Career Development Committee at ASCO
European Society of Medical Oncology (ESMO)
Research Center
Chao Family Comprehensive Cancer Center
Last updated
06/03/2019